The U.S. Court of Appeals for the 2nd Circuit issued a brief order Wednesday instructing the FDA to lift limits on the sales of the two-pill formulation of emergency contraceptive to women of all ages without a prescription until the court rules on the federal government's appeal to retain limits on the over-the-counter access to the drug. "Finally, after more than a decade of politically motivated delays, women will no longer have to endure intrusive, onerous, and medically unnecessary restrictions to get emergency contraception," Center for Reproductive Rights President and CEO Nancy Northup said in a statement.

Related Summaries